Wednesday 26 July 2017

Dermatology Devices Market Driven by Technological Innovations

Dermatology devices are devices and related adjuncts which aids dermatologists to treat skin disorders. Some of these devices are imaging devices, radiofrequency (RF) devices, cellulite-reducing devices, microdermabrasion devices, and lasers. It can aid in detecting skin cancer in its early stages. The demand of non-invasive techniques to treat such diseases is driving the global dermatology devices market. Alarming rise of obese populace is also expected to contribute to market growth. 

RF devices are considered to be the safest method for skin rejuvenation. Developments in these devices have led to better facial laxity and improvement regarding rhytides. At-home devices are a boon for consumers who wish to treat their skin within the confines of their houses. Blue LEDs (light-emitting diode) have the capacity to neutralize bacteria which contribute to inflammatory acne. Cellulite-reducing devices like SculpSure (Cynosure) possess the capacity to reduce body fat levels sufficiently. 

Developments in these devices have also led to its application in other areas such as burns and cancer diagnosis. RenovaCare’s SkinGun has the ability to treat burns by using stem cells of the patient. This treatment has a future potential to replace skin grafts. Damae Medical, a French startup, has developed an advanced imaging system (“Damae Medical System”) to detect tumors in its early stage. Its in vivo analysis can estimate the chances of tumor removal as well as follow up on its recurrence. 

The worldwide dermatology devices market is expected at USD 26 billion by 2025. It is anticipated to grow at a significant CAGR over the forecast period (2014 - 2025). It is driven by awareness of esthetic-related procedures among consumers regarding dermatology devices. Prevalence of various hair and skin related disorders are expected to drive market growth over the forecast period.

Diagnostic and treatment devices are two major products of the market. The former dominated the market in 2015 on account of being accepted by consumers to treat skin disorders. Hospitals were the biggest market end-user in 2015. Asia Pacific is expected to exhibit a lucrative CAGR over the forecast period. Key players in the global market are Cynosure, Inc.; Valeant Pharmaceuticals International Inc.; Avita Medical Ltd.; and GE Healthcare. 

No comments:

Post a Comment